Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsMaharasthra fda

    Maharasthra Fda

    Jump to

    • J&J to resume ops at Mulund plant after HC reprieve

      The Bombay HC has remanded the matter back to the Appellate Authority, directing it to hear J&J‘s application afresh. Armed with this order from the Bombay HC, J&J can now resume operations at its Mulund facility, which had been shut since June.

    • Johnson & Johnson seeks relief from HC on Maha FDA order

      In a bid to challenge the Maharashtra FDA decision to cancel license to manufacture cosmetics from the Mulund facility, Johnson and Johnson has moved the Bombay HC, reports CNBC-TV18's Ashmit Kumar.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347